Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127196122 | 12719612 | 2 | F | 20160913 | 20160907 | 20160920 | EXP | PHHY2015CR106971 | NOVARTIS | 57.00 | YR | M | Y | 86.00000 | KG | 20160920 | CN | COUNTRY NOT SPECIFIED | CR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127196122 | 12719612 | 1 | PS | TASIGNA | NILOTINIB | 1 | Unknown | 800 MG, QD (10 AM AND AT 3 PM) | 22068 | 800 | MG | CAPSULE | QD | ||||||
| 127196122 | 12719612 | 2 | SS | TASIGNA | NILOTINIB | 1 | Unknown | 800 MG, QD (2 AT 10 AM AND 2 AT 10 PM) | 22068 | 800 | MG | CAPSULE | QD | ||||||
| 127196122 | 12719612 | 3 | SS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, BID | 22068 | 400 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127196122 | 12719612 | 1 | Chronic myeloid leukaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127196122 | 12719612 | Abdominal discomfort | |
| 127196122 | 12719612 | Abdominal pain | |
| 127196122 | 12719612 | Abdominal pain upper | |
| 127196122 | 12719612 | Blister | |
| 127196122 | 12719612 | Constipation | |
| 127196122 | 12719612 | Eye irritation | |
| 127196122 | 12719612 | Fatigue | |
| 127196122 | 12719612 | Gastritis | |
| 127196122 | 12719612 | Hyperchlorhydria | |
| 127196122 | 12719612 | Incorrect drug administration duration | |
| 127196122 | 12719612 | Nasopharyngitis | |
| 127196122 | 12719612 | Rash | |
| 127196122 | 12719612 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |